Safety and tolerability of the ketogenic diet in pediatric epilepsy: Effects of valproate combination therapy

Epilepsia

Volumn 46, Issue 9, 2005, Pages 1533-1538

  Lyczkowski, David A ^a   Pfeifer, Heidi H ^a   Ghosh, Soumit ^a   Thiele, Elizabeth A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adverse event profile; Ketogenic diet; Valproic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; CARNITINE; CITRATE POTASSIUM; TRIACYLGLYCEROL; VALPROIC ACID; ANTICONVULSIVE AGENT; KETONE BODY;

ACIDOSIS; ACUTE PANCREATITIS; ARTICLE; CHILD; DRUG EFFECT; DRUG TOLERABILITY; EPILEPSY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFECTION; IRRITABILITY; KETOGENIC DIET; KIDNEY DISEASE; LETHARGY; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; SAFETY; THERAPY; BIOSYNTHESIS; COMPARATIVE STUDY; DIET THERAPY; ELEMENTAL DIET; FAT INTAKE; GASTROINTESTINAL DISEASE; INFANT; KETOACIDOSIS; METABOLISM; MULTIMODALITY CANCER THERAPY; PANCREATITIS; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ACIDOSIS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DIETARY FATS; EPILEPSY; FEMALE; FOOD, FORMULATED; GASTROINTESTINAL DISEASES; HUMANS; INFANT; KETONE BODIES; KETOSIS; MALE; PANCREATITIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VALPROIC ACID;

EID: 26944477076     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2005.22705.x     Document Type: Article

References (31)

1. Thiele EA. Assessing the efficacy of antiepileptic treatments: the ketogenic diet. Epilepsia 2003 44 ( suppl 7 S26 9.
2. Freeman JM Vining EPG Pillas DJ Pyzik PL Casey JC Kelly LM. The efficacy of the ketogenic diet, 1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998 102 : 1358 63.
3. Hemingway C Freeman JM Pillas DJ Pyzik PL. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001 108 : 898 905.
4. Kinsman SL Vining EPG Quaskey SA Mellits D Freeman JM. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 1992 33 : 1132 6.
5. Wheless JW. The ketogenic diet: an effective medical therapy with side effects. J Child Neurol 2001 16 : 633 5.
6. Kang HC Chung DE Kim DW Kim HD. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004 45 : 1116 23.
7. Ballaban-Gil K Callahan C O'Dell C Pappo M Moshé S Shinnar S. Complications of the ketogenic diet. Epilepsia 1998 39 : 744 8.
8. Rios VG. Complications of treatment of epilepsy by a ketogenic diet. Rev Neurol 2001 33 : 909 15.
9. Product Information, Depakote®, Depakene®, Abbott Laboratories, Inc., Physicians Desk Reference, Thomson PDR, Montvale, NJ, 2005.
10. Levy RH Matson RH Meldrum BS Perucca E, eds. Antiepileptic drugs, 5th ed. Philadelphia : Lippincott Williams & Wilkins, 2002.
11. De Vivo DC Bohin TP Coulter DL, et al. l-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia 1998 39 : 1216 25.
12. Kwiterovich PO Jr. Vining EPG Pyzik P Skolasky R Jr. Freeman JM. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA 2003 290 : 912 20.
13. Delgado MR Mills J Sparagana S. Hypercholesterolemia associated with the ketogenic diet. Epilepsia 1996 37 ( suppl 5 108.
14. Livingstone S Pauli LL Pruce I. Ketogenic diet in the treatment of childhood epilepsy. Dev Med Child Neurol 1977 19 : 833 4.
15. Bryant AE Dreifuss FE. Valproic acid hepatic fatalities. III. US experience since 1986. Neurology 1996 46 : 465 9.
16. Buse GJ Riley KD Dress CM Neumaster TD. Patient with gemfibrozil- controlled hypertriglyceridemia that developed acute pancreatitis after starting ketogenic diet. Curr Surg 2004 61 ( 2 224 6.
17. Stewart WA Gordon K Camfield P. Acute pancreatitis causing death in a child on the ketogenic diet. J Child Neurol 2001 16 ( 9 682.
18. Chapman SA Wachsman GP Patterson BD. Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy 2001 21 ( 12 1549 60.
19. Asconapé JJ Penry JK Dreifuss FE, et al. Valproate associated pancreatitis. Epilepsia 1993 34 : 177 83.
20. Knorr M Schaper J Harjes M Mayatepek E Rosenbaum T. Fanc-71.
21. Lande MB Kim MS Bartlett C Guay-Woodford LM. Reversible Fanconi syndrome associated with valproate therapy. J Pediatr 1993 123 : 320 2.
22. Lenoir GR Perignon JL Broyer M. Valproic acid: a possible cause of proximal tubular renal syndrome. J Pediatr 1981 98 : 503 4.
23. Jeavons PM. Non-dose related side effects of valproate. Epilepsia 1984 25 ( suppl 1 S50 5.
24. Coulter DL. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity ( letter). Lancet 1984 323 ( 8378 689.
25. Dreifuss FE Santilli N Langer DH Sweeney KP Moline KA Menander KB. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987 37 : 379 85.
26. Ater SB Benefield WH Saklad JJ Saklad SR. A developmental center population treated with VPA and L-carnitine. In : Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals, 1993.
27. Coulter DL Wu H Allen RJ. Valproic acid therapy in childhood epilepsy. JAMA 1980 244 : 785 8.
28. Berry-Kravis E Booth G Sanchez AC Woodbury-Kolb J. Carnitine levels and the ketogenic diet. Epilepsia 2001 42 : 1445 51.
29. Hirose S Mitsudome A Yasumoto S Ogawa A Muta Y Tomoda Y. Valproate therapy does not deplete carnitine levels in otherwise healthy children. Pediatrics 1998 101 ( 5 E9.
30. Fung EL Tang NL Ho CS Lam CW Fok TF. Carnitine level in Chinese epileptic patients taking sodium valproate. Pediatr Neurol 2003 28 : 24 7.
31. Bohan TP Helton E McDonald I, et al. Effect of l-carnitine treatment for valproate-induced hepatotoxicity (brief communication). Neurology 2001 56 : 1405 9.